Relative Effectiveness and Immunogenicity of Quadrivalent Recombinant Influenza Vaccine Versus Egg-Based Inactivated Influenza Vaccine Among Adults Aged 18–64 Years: Results and Experience From a Randomized, Double-Blind Trial

Relative VE of RIV compared to SD IIV did not reach statistical significance, but RIV elicited more robust humoral immune responses to 2 of 4 vaccine viruses at 1 month and 3 of 4 viruses at 6 months after vaccination, suggesting possible improved and sustained immune protection from RIV. <b>Clinical Trials Registration.</b> NCT05514002.

Authors

Institutions

Publication Details

Journal
Open Forum Infectious Diseases
Published
2024-09-26
DOI
https://doi.org/10.1093/ofid/ofae559
Citations
8
Primary Topic
Influenza Virus Research Studies
Type
article
Field-Weighted Citation Impact
3.09

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Relative Effectiveness and Immunogenicity of Quadrivalent Recombinant Influenza Vaccine Versus Egg-Based Inactivated Influenza Vaccine Among Adults Aged 18–64 Years: Results and Experience From a Randomized, Double-Blind Trial

Jacob Mckell, Fatimah S. Dawood, E. Nuez Zaragoza, Hana M. El Sahly et al.
8 citations
Open Forum Infectious Diseases
Influenza Virus Research Studies
3.09
article

Relative Effectiveness and Immunogenicity of Quadrivalent Recombinant Influenza Vaccine Versus Egg-Based Inactivated Influenza Vaccine Among Adults Aged 18–64 Years: Results and Experience From a Randomized, Double-Blind Trial

Jacob Mckell, Fatimah S. Dawood, E. Nuez Zaragoza, Hana M. El Sahly, Rebecca V. Fink, Jennifer A. Whitaker, Jesse Feiring Williams, Jennifer K. Meece, Fornessa T. Randal, Sarah W. Ball, Matthew S. Thiese, Riley Campbell, Kristina Wielgosz, Lenee Blanton, Andrew L. Phillips, Sarang K. Yoon, Kurt T. Hegmann, John Barnes, Ashley A. Lowe, Lauren Grant, Min Z. Levine, Karen Lutrick, Alia Southworth, Alicia M. Fry, Steph Battan-Wraith, Rachel M. Brown, Tanya Tatum, Julie Mayo-Lamberte, C Perry Brown, Catherine Healy, S. K. Bhargava
article en
8 citations

Abstract

Relative VE of RIV compared to SD IIV did not reach statistical significance, but RIV elicited more robust humoral immune responses to 2 of 4 vaccine viruses at 1 month and 3 of 4 viruses at 6 months after vaccination, suggesting possible improved and sustained immune protection from RIV. <b>Clinical Trials Registration.</b> NCT05514002.

Open Forum Infectious DiseasesVol. 11(10)
Centers for Disease Control and Prevention (US), Westat (United States) (US), University of Arizona (US), Baylor College of Medicine (US), University of Utah (US), University of Chicago (US), Asian Health Coalition (US), CVS Health (United States) (US), Marshfield Clinic (US), Florida Agricultural and Mechanical University (US), Rocky Mountain University of Health Professions (US)
Emory University, National Institutes of Health, Centers for Disease Control and Prevention
Openalex Percentile: Top 8%
Influenza Virus Research Studies
3.09
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.